Biotech · Private company
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Track this companyFree. Adds Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair to your Dealase workspace and tells you when its record changes.
Clinical trials55 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Abiraterone - StudyPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone - UsualPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Raloxifene - StudyPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Raloxifene - UsualPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous usePhase 1 · HPV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CEA protein antigen plus BCG Vaccine Mix for percutaneous usePhase 1 · Rectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous usePhase 1 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide PolymorphismsPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 21, 2025ClinicalTrials.gov NCT06062810 · fetched Nov 12, 2026
- Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic MixEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started May 18, 2025ClinicalTrials.gov NCT03305341 · fetched Nov 12, 2026
- Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPVEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 28, 2025ClinicalTrials.gov NCT06959563 · fetched Nov 12, 2026
- Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide PolymorphismsPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 18, 2023ClinicalTrials.gov NCT03348670 · fetched Nov 12, 2026
- Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 28, 2021ClinicalTrials.gov NCT02403505 · fetched Nov 12, 2026